19-10986523-CGGCCCTGGCCCTGGCCCT-CGGCCCTGGCCCTGGCCCTGGCCCTGGCCCT

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP3BP6

The NM_003072.5(SMARCA4):​c.702_713dupTGGCCCTGGCCC​(p.Pro238_Gly239insGlyProGlyPro) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.0000013 in 1,543,526 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P238P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

SMARCA4
NM_003072.5 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 6.83

Publications

1 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • otosclerosis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003072.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003072.5
BP6
Variant 19-10986523-C-CGGCCCTGGCCCT is Benign according to our data. Variant chr19-10986523-C-CGGCCCTGGCCCT is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 826778.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003072.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
NM_001387283.1
MANE Plus Clinical
c.702_713dupTGGCCCTGGCCCp.Pro238_Gly239insGlyProGlyPro
disruptive_inframe_insertion
Exon 4 of 36NP_001374212.1Q9HBD4
SMARCA4
NM_003072.5
MANE Select
c.702_713dupTGGCCCTGGCCCp.Pro238_Gly239insGlyProGlyPro
disruptive_inframe_insertion
Exon 4 of 35NP_003063.2
SMARCA4
NM_001128849.3
c.702_713dupTGGCCCTGGCCCp.Pro238_Gly239insGlyProGlyPro
disruptive_inframe_insertion
Exon 4 of 36NP_001122321.1Q9HBD4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
ENST00000646693.2
MANE Plus Clinical
c.702_713dupTGGCCCTGGCCCp.Pro238_Gly239insGlyProGlyPro
disruptive_inframe_insertion
Exon 4 of 36ENSP00000495368.1Q9HBD4
SMARCA4
ENST00000344626.10
TSL:1 MANE Select
c.702_713dupTGGCCCTGGCCCp.Pro238_Gly239insGlyProGlyPro
disruptive_inframe_insertion
Exon 4 of 35ENSP00000343896.4P51532-1
SMARCA4
ENST00000643549.1
c.702_713dupTGGCCCTGGCCCp.Pro238_Gly239insGlyProGlyPro
disruptive_inframe_insertion
Exon 4 of 35ENSP00000493975.1A0A2R8Y4P4

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
7.19e-7
AC:
1
AN:
1391208
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
686496
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31580
American (AMR)
AF:
0.00
AC:
0
AN:
35666
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25116
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35728
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79182
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41640
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078664
Other (OTH)
AF:
0.00
AC:
0
AN:
57938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152318
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41574
American (AMR)
AF:
0.00
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
2
-
Rhabdoid tumor predisposition syndrome 2 (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.8
Mutation Taster
=80/20
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs372601826;
hg19: chr19-11097199;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.